학술논문
A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough
Document Type
Article
Author
Source
In Allergology International October 2022 71(4):498-504
Subject
Language
ISSN
1323-8930